Syngene International Ratios

Syngene International Ltd Ratios

The Syngene International Ltd Ratios page provides a complete fundamental analysis of Syngene International Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Syngene International Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Syngene International Ltd (NSE: SYNGENE, BSE: 539268) is currently trading at ₹414.75, with a market capitalization of ₹167.08B. As a major player in the Commercial services sector and Miscellaneous commercial services industry, Syngene International Ltd remains a key stock for fundamental analysis using Syngene International Ltd Ratios.

Syngene International Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Syngene International Ltd P/E ratio currently stands at 58.87, making it one of the most tracked metrics in Syngene International Ltd Ratios.

Historically, the Syngene International Ltd P/E ratio has shown strong fluctuations:

• 2024: 58.87
• 2023: 55.31
• 2022: 51.67
• 2021: 60.76
• 2020: 53.77

The rising Syngene International Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Syngene International Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 6.17.

Historical P/B trend:

• 2024: 6.17
• 2023: 6.60
• 2022: 6.57
• 2021: 7.24

Syngene International Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Syngene International Ltd P/S ratio currently stands at 8.04, an important part of Syngene International Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 8.04
• 2023: 8.09
• 2022: 7.53
• 2021: 9.23

A stable or declining Syngene International Ltd P/S ratio indicates cautious market sentiment.

Syngene International Ltd Price to Cash Flow Ratio (P/CF)

The Syngene International Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 24.26.

Historical Syngene International Ltd Price to Cash Flow Ratio:

• 2024: 24.26
• 2023: 25.77
• 2022: 28.47
• 2021: 40.80
• 2020: 29.60

The declining Syngene International Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Syngene International Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Syngene International Ltd EV currently stands at ₹283.93B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 283.93B
• 2023: 276.85B
• 2022: 234.57B
• 2021: 237.89B

Syngene International Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Syngene International Ltd EV/EBITDA ratio is currently 26.92, a key metric in Syngene International Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 26.92
• 2023: 25.57
• 2022: 23.61
• 2021: 31.69

Higher Syngene International Ltd EV/EBITDA suggests premium valuation.

Syngene International Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Syngene International Ltd D/E ratio is currently 0.12, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.12
• 2023: 0.13
• 2022: 0.23
• 2021: 0.31

Syngene International Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Syngene International Ltd ROE currently stands at 11.05%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 11.05
• 2023: 12.95
• 2022: 13.43
• 2021: 12.94

Syngene International Ltd maintains stable profitability levels.

Syngene International Ltd Ratios Analysis Summary

The Syngene International Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Syngene International Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Syngene International Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.